Results 1 to 10 of about 25,335 (131)

Comparative efficacy and safety of etanercept and adalimumab in the treatment of polyarticular juvenile idiopathic arthritis. [PDF]

BMC Pediatr
Ge L, Gao Y, Chen X, Guo J, Zhang D, Yang Y.   +5 more
europepmc   +1 more source

Osteoclast development from peripheral blood monocytes is reduced in patients with radiographic axial spondyloarthritis on biological therapy. [PDF]

Arthritis Res Ther
Engdahl C, Erlandsson MC, Hallström M, Deminger A, Forsblad-d'Elia H.   +4 more
europepmc   +1 more source

Trends in New Use of Disease-Modifying Antirheumatic Drugs for Juvenile Idiopathic Arthritis Among Commercially Insured Children in the United States from 2001 to 2022. [PDF]

Arthritis Rheumatol
Yalamanchili P, Lee LY, Bushnell G, Mannion ML, Dave CV, Horton DB.   +5 more
europepmc   +1 more source

Trends in Psoriatic Arthritis Management From 1993 to 2019: Rise of Biologics and Decline of Oral Small Molecules. [PDF]

J Psoriasis Psoriatic Arthritis
Woodie BR, Balachandar S, Fleischer AB.
europepmc   +1 more source

Abatacept, Golimumab, and Sarilumab as Selected Bio-Originator Disease-Modifying Antirheumatic Drugs with Diverse Mechanisms of Action in Their Current Use in Treatment. [PDF]

J Clin Med
Kawczak P, Feszak IJ, Bączek T.
europepmc   +1 more source

Real-World Safety and Efficacy of Targeted Therapies in Rheumatoid Arthritis: A 5-Year, 5130-Case Follow-Up from FIRST Registry. [PDF]

Rheumatol Ther
Sonomoto K, Nakayamada S, Tanaka H, Nagayasu A, Tanaka Y.   +4 more
europepmc   +1 more source

Detection of substantial numbers of latent tuberculosis and positive hepatitis B serology results in rheumatology patients preparing to receive intensified immunosuppressive therapy in a low-prevalence country: why screening still matters. [PDF]

Clin Rheumatol
Feuchtenberger M, Kovacs MS, Nigg A, Schäfer A.   +3 more
europepmc   +1 more source

Risk of Serious Infections in Patients Treated With Biologic or Targeted-synthetic Disease Modifying Antirheumatic Drugs in Qatar. [PDF]

Immun Inflamm Dis
Sasi S, Hadi HA, Chaponda M, El Ajez R, Ataelmanan M, Khasawneh S, Saqallah H, Ali M, Abdulla N, Iqbal J, Omrani AS, Al Maslamani M, Al-Khal A.   +12 more
europepmc   +1 more source

Clinical remission rate and drug withdrawal status in articular juvenile idiopathic arthritis. [PDF]

Pediatr Rheumatol Online J
Oshima A, Ebato T, Kaneko M, Shikama Y, Imagawa T.   +4 more
europepmc   +1 more source